Showing results (371-380 of 401) with videos related to
Sort By:
Pageof 41
Plos One|August 18, 2012
MRI detects brain reorganization after human umbilical tissue-derived cells (hUTC) treatment of stroke in ratQuan Jiang, Christine Thiffault, Brian C Kramer, et al.Plos Pathogens|August 14, 2015
Nanoformulations of Rilpivirine for Topical Pericoital and Systemic Coitus-Independent Administration Efficiently Prevent HIV TransmissionMartina Kovarova, Olivia D Council, Abhijit A Date, et al.Retrovirology|November 19, 2013
Primate lentiviral Nef proteins deregulate T-cell development by multiple mechanismsAnouk Van Nuffel, Kevin K Ariën, Veronique Stove, et al.Antimicrobial Agents and Chemotherapy|October 16, 2019
Antiretroviral Penetration across Three Preclinical Animal Models and Humans in Eight Putative HIV Viral ReservoirsAaron S Devanathan, Jason R Pirone, Ramesh Akkina, et al.The Journal of Clinical Investigation|June 15, 2023
An allosteric inhibitor of sirtuin 2 deacetylase activity exhibits broad-spectrum antiviral activityKathryn L Roche, Stacy Remiszewski, Matthew J Todd, et al.Antimicrobial Agents and Chemotherapy|July 15, 2020
Antiretroviral Penetration and Drug Transporter Concentrations in the Spleens of Three Preclinical Animal Models and HumansAaron S Devanathan, John K Fallon, Nicole R White, et al.Molecular Biology of the Cell|July 26, 2013
Arp2/3 complex is essential for actin network treadmilling as well as for targeting of capping protein and cofilinStefan A Koestler, Anika Steffen, Maria Nemethova, et al.Research Square|September 30, 2020
Acute SARS-CoV-2 Infection is Highly Cytopathic, Elicits a Robust Innate Immune Response and is Efficiently Prevented by EIDD-2801Angela Wahl, Lisa Gralinski, Claire Johnson, et al.Plos One|September 9, 2010
Amino-acid co-variation in HIV-1 Gag subtype C: HLA-mediated selection pressure and compensatory dynamicsMorgane Rolland, Jonathan M Carlson, Siriphan Manocheewa, et al.Journal of Virology|May 20, 2011
One percent tenofovir applied topically to humanized BLT mice and used according to the CAPRISA 004 experimental design demonstrates partial protection from vaginal HIV infection, validating the BLT model for evaluation of new microbicide candidatesPaul W Denton, Florence Othieno, Francisco Martinez-Torres, et al.Pageof 41